Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.190
-0.060 (-4.80%)
At close: Nov 20, 2024, 4:00 PM
1.250
+0.060 (5.04%)
Pre-market: Nov 21, 2024, 4:45 AM EST
Allarity Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | - | - | - | - | - | 0.8 | Upgrade
|
| Other Revenue | - | - | - | - | - | 2.1 | Upgrade
|
| Revenue | - | - | - | - | - | 2.9 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | -69.52% | Upgrade
|
| Cost of Revenue | - | - | - | - | - | 46.82 | Upgrade
|
| Gross Profit | - | - | - | - | - | -43.92 | Upgrade
|
| Selling, General & Admin | 8.23 | 10.03 | 9.96 | 12.36 | 4.1 | 22.58 | Upgrade
|
| Research & Development | 7.67 | 7.9 | 7.64 | 14.2 | 4.22 | - | Upgrade
|
| Other Operating Expenses | -0.8 | -0.8 | -0.71 | - | - | - | Upgrade
|
| Operating Expenses | 15.1 | 17.13 | 16.89 | 26.56 | 8.32 | 23.68 | Upgrade
|
| Operating Income | -15.1 | -17.13 | -16.89 | -26.56 | -8.32 | -67.6 | Upgrade
|
| Interest Expense | -0.81 | -0.5 | -0.22 | -0.59 | -0.32 | -26.57 | Upgrade
|
| Interest & Investment Income | 0.32 | 0.02 | 0.03 | - | - | 0.05 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.29 | 0.13 | -0.91 | -0.1 | 0.06 | -0.29 | Upgrade
|
| Other Non Operating Income (Expenses) | 5.92 | 5.65 | 17.13 | 0.35 | 1.56 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -9.38 | -11.82 | -0.87 | -26.88 | -7.02 | -94.43 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.12 | -0.5 | 0.71 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 1.78 | 1.01 | - | - | Upgrade
|
| Asset Writedown | -9.7 | - | -17.57 | - | - | -80.5 | Upgrade
|
| Other Unusual Items | - | - | -0.8 | -0.14 | -0.11 | - | Upgrade
|
| Pretax Income | -19.08 | -11.82 | -17.58 | -26.52 | -6.42 | -174.92 | Upgrade
|
| Income Tax Expense | -0.3 | 0.08 | -1.52 | 0.13 | 0.2 | -36.79 | Upgrade
|
| Earnings From Continuing Operations | -18.78 | -11.9 | -16.06 | -26.65 | -6.62 | -138.13 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 0.02 | 6.18 | Upgrade
|
| Net Income | -18.78 | -11.9 | -16.06 | -26.65 | -6.6 | -131.96 | Upgrade
|
| Preferred Dividends & Other Adjustments | 16.39 | 8.52 | 4.99 | - | - | - | Upgrade
|
| Net Income to Common | -35.18 | -20.42 | -21.05 | -26.65 | -6.6 | -131.96 | Upgrade
|
| Shares Outstanding (Basic) | 1 | - | - | - | - | - | Upgrade
|
| Shares Outstanding (Diluted) | 1 | - | - | - | - | - | Upgrade
|
| EPS (Basic) | -66.84 | - | - | - | - | - | Upgrade
|
| EPS (Diluted) | -66.84 | - | - | - | - | - | Upgrade
|
| Free Cash Flow | - | -12.75 | -16.84 | -14.89 | -7.25 | -72.47 | Upgrade
|
| Operating Margin | - | - | - | - | - | -2330.37% | Upgrade
|
| Profit Margin | - | - | - | - | - | -4548.60% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -2498.14% | Upgrade
|
| EBITDA | -15.09 | -17.09 | -16.83 | -26.45 | -8.27 | -67.17 | Upgrade
|
| D&A For EBITDA | 0.01 | 0.04 | 0.06 | 0.11 | 0.05 | 0.43 | Upgrade
|
| EBIT | -15.1 | -17.13 | -16.89 | -26.56 | -8.32 | -67.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.